IHRC launches chatbot about cervical cancer screening
The NKCx Chatbot adds to the e-learning profile of the International Human Papillomavirus Reference Center aiming to increase the knowledge…
Category: Uncategorized
Read More
Joint EU Guidelines on Cervical Cancer Screening Published
The European Union has released its long-awaited guidelines on cervical cancer screening and diagnosis. These recommendations mark a major step…
IHRC contributes to HPV self-sampling initiative in war-affected Ukraine
Cervical cancer is the fourth most common cause of cancer-related deaths among women globally, despite being largely preventable. In war-affected…
HPV 230 OFICIALLY ESTABLISHED!
A putative novel HPV type was just officially established by the IHRC. As of September 2023, the type numbers are…
Eurogin 2024, March 13-16 in Stockholm. Save the date!
EUROGIN: International Multidisciplinary HPV Congress EUROGIN 2024 will be held at Waterfront Congress Centre, in Stockholm, March 13-16. Save the…
International Collaborative Study on Sensitivity and Specificity for CIN2+ of Viral load and Types of HPV
An international definition of desirable detection limits would greatly facilitate both quality assurance and development/validation of new HPV tests. A…
WHO public report available on HPV antibody standards for HPV types 6, 11, 31, 33, 45 and 52.
The WHO Expert Committee on Biological Standardization has recently published for public consultation the report on HPV antibody standards for…
TV4 “Nya målet: Utrota HPV-viruset”
På TV4 “Efter fem” från den 19 oktober kan ni ta del av det “Nya målet: Utrota HPV-viruset“, där professor…
The Carina Eklund Symposium: 30 years of HPV research
In April 2019, it has been 30 years since Project Coordinator Carina Eklund started working at Professor Joakim Dillner´s research group at Karolinska Insitute. At…
eLearning course on Human Papillomavirus
Nordic eScience has created a youtube channel (www.youtube.com/NordiceScienceHPV) where users can find different webinars and electures about HPV. Special attention…
- 1
- 2